Abstract
Objectives
To assess the added value of diffusion-weighted imaging (DWI) to conventional magnetic resonance imaging (MRI) for differentiating benign from malignant bile duct strictures.
Methods
Twenty-seven patients with a benign stricture and 42 patients with a malignant stricture who had undergone gadoxetic acid-enhanced MRI with DWI were enrolled. Qualitative (signal intensity, dynamic enhancement pattern) and quantitative (wall thickness and length) analyses were performed. Two observers independently reviewed a set of conventional MRI and a combined set of conventional MRI and DWI, and receiver operating characteristic (ROC) curve analysis was assessed.
Results
Benign strictures showed isointensity (18.5–70.4 %) and a similar enhancement pattern (22.2 %) to that of normal bile duct more frequently than malignant strictures (0–40.5 % and 0 %) on conventional MRI (P < 0.05). Malignant strictures (90.5–92.9 %) showed hypervascularity on arterial and portal venous phase images more frequently than benign strictures (37.0–70.4 %) (P < 0.01) On DWI, all malignant strictures showed hyperintensity compared with benign cases (70.4 %) (P < 0.001). Malignant strictures were significantly thicker and longer than benign strictures (P < 0.001). The diagnostic performance of both observers improved significantly after additional review of DWI.
Conclusions
Adding DWI to conventional MRI is more helpful for differentiating benign from malignant bile duct strictures than conventional MRI alone.
Key points
• Accurate diagnosis and exclusion of benign strictures of bile duct are important.
• Diffusion-weighted MRI helps to distinguish benign from malignant bile duct strictures.
• DWI plus conventional MRI provides superior diagnostic accuracy to conventional MRI alone.
Similar content being viewed by others
References
Fulcher AS, Turner MA, Capps GW, Zfass AM, Baker KM (1998) Half-Fourier RARE MR cholangiopancreatography: experience in 300 subjects. Radiology 207:21–32
Park MS, Kim TK, Kim KW et al (2004) Differentiation of extrahepatic bile duct cholangiocarcinoma from benign stricture: findings at MRCP versus ERCP. Radiology 233:234–240
Worawattanakul S, Semelka RC, Noone TC, Calvo BF, Kelekis NL, Woosley JT (1998) Cholangiocarcinoma: spectrum of appearances on MR images using current techniques. Magn Reson Imaging 16:993–1003
Thuluvath PJ, Rai R, Venbrux AC, Yeo CJ (1997) Cholangiocarcinoma: a review. Gastroenterologist 5:306–315
Lee WJ, Lim HK, Jang KM et al (2001) Radiologic spectrum of cholangiocarcinoma: emphasis on unusual manifestations and differential diagnoses. Radiographics 21:97–116
Kim JY, Lee JM, Han JK et al (2007) Contrast-enhanced MRI combined with MR cholangiopancreatography for the evaluation of patients with biliary strictures: differentiation of malignant from benign bile duct strictures. J Magn Reson Imaging 26:304–312
Padhani AR, Liu G, Koh DM et al (2009) Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia 11:102–125
Taouli B, Koh DM (2010) Diffusion-weighted MR imaging of the liver. Radiology 254:47–66
Parikh T, Drew SJ, Lee VS et al (2008) Focal liver lesion detection and characterization with diffusion-weighted MR imaging: comparison with standard breath-hold T2-weighted imaging. Radiology 246:812–822
Fulcher AS, Turner MA, Zfass AM (1998) Magnetic resonance cholangiopancreatography: a new technique for evaluating the biliary tract and pancreatic duct. Gastroenterologist 6:82–87
Soto JA, Alvarez O, Lopera JE, Munera F, Restrepo JC, Correa G (2000) Biliary obstruction: findings at MR cholangiography and cross-sectional MR imaging. Radiographics 20:353–366
Soyer P, Bluemke DA, Reichle R et al (1995) Imaging of intrahepatic cholangiocarcinoma: 2. Hilar cholangiocarcinoma. AJR Am J Roentgenol 165:1433–1436
Schulte SJ, Baron RL, Teefey SA et al (1990) CT of the extrahepatic bile ducts: wall thickness and contrast enhancement in normal and abnormal ducts. AJR Am J Roentgenol 154:79–85
Lacomis JM, Baron RL, Oliver JH 3rd, Nalesnik MA, Federle MP (1997) Cholangiocarcinoma: delayed CT contrast enhancement patterns. Radiology 203:98–104
Park HS, Lee JM, Kim SH et al (2006) CT Differentiation of cholangiocarcinoma from periductal fibrosis in patients with hepatolithiasis. AJR Am J Roentgenol 187:445–453
Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159–174
Park MS, Yu JS, Kim KW et al (2001) Recurrent pyogenic cholangitis: comparison between MR cholangiography and direct cholangiography. Radiology 220:677–682
Koga A, Ichimiya H, Yamaguchi K, Miyazaki K, Nakayama F (1985) Hepatolithiasis associated with cholangiocarcinoma. Possible etiologic significance. Cancer 55:2826–2829
Park KW, Lim JH, Jang KT, Choi DW (2008) Autoimmune cholangitis mimicking periductal-infiltrating cholangiocarcinoma. Abdom Imaging 33:334–336
Chung DT, Tang CN, Lai EC, Yang GP, Li MK (2010) Immunoglobulin G4-associated sclerosing cholangitis mimicking cholangiocarcinoma. Hong Kong Med J 16:149–152
Finkelberg DL, Sahani D, Deshpande V, Brugge WR (2006) Autoimmune pancreatitis. N Engl J Med 355:2670–2676
Nishino T, Toki F, Oyama H et al (2005) Biliary tract involvement in autoimmune pancreatitis. Pancreas 30:76–82
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Park, H.J., Kim, S.H., Jang, K.M. et al. The role of diffusion-weighted MR imaging for differentiating benign from malignant bile duct strictures. Eur Radiol 24, 947–958 (2014). https://doi.org/10.1007/s00330-014-3097-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00330-014-3097-x